Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,584 | -$33,970 | -$63,344 | -$8,331 |
| Dep. & Amort. | $1,028 | $822 | $548 | $497 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16,031 | $19,008 | $15,782 | $22,595 |
| Change in WC | -$544 | -$2,140 | $509 | -$3,429 |
| Other Non-Cash | $4,573 | -$34,956 | -$10 | -$43,577 |
| Operating Cash Flow | -$35,496 | -$51,236 | -$46,515 | -$32,245 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$268 | -$1,229 | -$1,619 | -$506 |
| Net Acquisitions | $0 | $0 | -$851 | $0 |
| Inv. Purchases | -$58,720 | -$73,261 | -$73,817 | $0 |
| Inv. Sales/Matur. | $77,550 | $104,350 | $3,000 | $0 |
| Other Inv. Act. | $1,247 | $0 | $851 | $0 |
| Investing Cash Flow | $19,809 | $29,860 | -$72,436 | -$506 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5,000 | $0 | $29,574 | -$2,848 |
| Stock Issued | $18,632 | $395 | $317 | $73,648 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$47 | -$162 | -$886 | $26 |
| Financing Cash Flow | $13,585 | $233 | $29,005 | $77,146 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,102 | -$21,143 | -$89,946 | $44,395 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,364 | $27,507 | $117,453 | $73,058 |
| End Cash | $4,262 | $6,364 | $27,507 | $117,453 |
| Free Cash Flow | -$35,764 | -$52,465 | -$48,134 | -$32,751 |